Chinese Pharmaceutical Market Overview

Questions: Discounts, Updates etc.

Price: $15,200.00

Publication Date: 2006-12-19

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

The Chinese pharmaceutical market, although only positioned ninth globally, has experienced pronounced and rapid expansion in recent years, driven by the growth of both Chinese and Western manufacturers. Increasingly, there is a shift towards a research-based industry, focused on generating new, innovative therapies, supported by improving intellectual property regulations.


Scope

  • Overview of macro-environmental and regulatory issues affecting the Chinese pharmaceutical industry
  • Assessment of the Chinese pharmaceutical market, analyzing the key prescription therapy areas, as well as OTC and TCM medicines
  • Case study analysis of key Western and Chinese manufacturers in China
  • Insight into the key opportunities for Western manufacturers in China, and the areas likely to provide revenue growth in the future


    • Report Highlights
    With improvements in intellectual property regulations, Government funding and the growth of tax incentivized Special Economic Zones, China's R&D environment is developing fast. Western manufacturers are increasingly looking towards China as a place to conduct drug discovery and clinical trial research, although a number of challenges still remain.

    China is becoming an increasingly competitive environment due to ongoing price competition, and numerous Governmental price cuts. Unless Western manufacturers have Chinese based manufacturing plants which can produce generic drugs at low-cost, there is little financial incentive or future prospects for foreign companies in the generics market.

    China still exemplifies the disease and treatment profile of a developing market, with a focus on prescribing anti-infectives. However, with westernization of diet and lifestyle, and China's improving healthcare system, treatment of more chronic disorders will eventually become more of a priority in the future.


    Reasons to Purchase

  • Understand the dynamics of the Chinese pharmaceutical market and the effect of recent changes to pricing, reimbursement and patent regulations
  • Identify China's R&D attractions, which are encouraging Western manufacturers to off-shore and out source drug discovery and clinical trials in China
  • Optimize your Chinese market growth strategy through detailed knowledge of the performance of the Chinese and Western manufacturers in China

    • Table of Contents

    Other users found this report page using the following search terms: china chinese pharmaceutical api manufacturer anti franchise diabetes ten industry issues regulatory

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.